Press releases
DexTech Medical decision on allocation regarding incentive programs
17 November, 2022At the Annual General Meeting of DexTech AB (“DexTech” or the “Company”) on 28 October 2022, it was resolved to introduce an incentive program (“W 2022 /2025”) for pre-selected key […]
Bulletin from the Annual General Meeting
28 October, 2022Today, 28 October 2022, the Annual General Meeting of DexTech Medical AB was held. All decisions were taken by the required majority. Resolution on adoption of the income statement and […]
Interim report July 1 – September 30, 2022
27 October, 2022Summary of the first quarter (2022-07-01 – 2022-09-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -0,8 (-0,9) Earnings per share* SEK -0,04 (-0.06) Cash and […]
Dextech Medical AB (publ) Notice to AGM 2022
28 September, 2022WELCOME TO THE ANNUAL GENERAL MEETING 2022 IN DEXTECH MEDICAL AB (publ) Dextech Medical AB’s shareholders are welcome to attend the Annual General Meeting that is taking place on Friday, […]
DexTech Medical announces upcoming multiple myeloma study
27 September, 2022The application for an Fas1 study regarding the effect of OsteoDex on patients with multiple myeloma (MM) was approved and granted permission by the Medical Products Agency on August 10, […]
Dextech Medical AB Annual report 210701-220630
20 September, 2022Download the annual report below. Dextech Medical AB Annual report 210701-220630
Year-end report July 1, 2021 – June 30, 2022
30 August, 2022Summary of the fourth quarter (2022-04-01 – 2022-06-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -2,1 (-1,5) Earnings per share* SEK -0.11 (-0.10) * Before […]
DexTech Medical’s application for myeloma study approved
10 August, 2022The application for a phase1 study regarding OsteoDex’s effect on patients with multiple myeloma that was submitted to the Medical Products Agency on 2022-06-23 has been approved and granted permission […]
Report from the Extraordinary General Meeting
11 May, 2022Today, May 11, 2022, the Extra General Meeting of DexTech Medical AB was held. Below is a summary of the decisions made. All decisions were made by the required majority. […]
Interim report July 1, 2021 – March 31, 2022
29 April, 2022By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the third quarter (2022-01-01 – 2022-03-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]